A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A15.3 KBArno Therapeutics, IncJan 3, 5:20 PM ET·0001535610-18-000002
- SC 13G/A111.9 KBArno Therapeutics, IncFeb 14, 5:01 PM ET·0001019056-17-000207
- SC 13G/A42.2 KBArno Therapeutics, IncFeb 14, 4:28 PM ET·0001193125-17-043481
- SC 13G/A144.1 KBArno Therapeutics, IncFeb 14, 4:23 PM ET·0001011438-17-000149
- 35.4 KBArno Therapeutics, IncJan 9, 12:50 PM ET·0001359824-17-000009
- SC 13D93.3 KBArno Therapeutics, IncJan 9, 12:49 PM ET·0001359824-17-000008
- SC 13G/A15.3 KBArno Therapeutics, IncJan 5, 2:20 PM ET·0001535610-17-000002
- 411.0 KBArno Therapeutics, IncJan 3, 4:27 PM ET·0001359824-17-000005
- SC 13D/A140.8 KBArno Therapeutics, IncJan 3, 4:25 PM ET·0001359824-17-000004
- 10-Q4.7 MBArno Therapeutics, IncNov 14, 4:08 PM ET·0001144204-16-134183
Insiders
10- Belldegrun ArieDirector
- Berlin Roger GDirector, Chief Executive Officer
- DAVIDSON CHARLES ENo longer own 10% of Issuer
- HAMILTON WILLIAM F PHDDirector
- JACOBS JOSEPHNo longer own 10% of Issuer
- Kariv TomerDirector
- KENYON LAWRENCE AChief Financial Officer
- Mattes Glenn R.Director, President & CEO
- Moorin JayDirector
- Navins Scott LTreasurer
Tickers
No tickers on record
Addresses
business
200 ROUTE 31 NORTH SUITE 104
FLEMINGTON, NJ, 08822
mailing
200 ROUTE 31 NORTH SUITE 104
FLEMINGTON, NJ, 08822
Former Names
- LAURIER INTERNATIONAL INC2008-04-29